supported by a grant from the National Key Technology R&D Program of the Ministry of Science and Technology of China (No.2004BA719A09-0203)
Objective: To observe the therapeutic effects of Jingyuankang capsules (精元康胶囊) for leukopenia in AIDS patients. Methods: In this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog...